AIDS WEEKLY Plus - March - 1999Important note: Information in this article was accurate in March 1999. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

AIDS Pathogenesis: PGQM Could Spell Trouble for HIV

AIDSWEEKLY Plus; Monday, March 29, 1999
Daniel J. DeNoon, Senior Editor


A conserved segment of the HIV Gag protein may be a new target for AIDS therapies.

HIV-1 Gag plays several vital roles in replication of the AIDS virus. Now mutational analysis of the Gag protein reveals that its capsid region contains a unique proline-glycine-glutamine-methionine (PGQM) amino-acid motif. Without the motif the virus cannot replicate. Importantly, HIV-1 with alanine (A) mutations in the G and Q residues of this motif also were unable to replicate.

"Our results suggest potential strategies for developing anti-HIV-1 agents based on the loop containing the PGQM motif present in the capsid protein," wrote M. Srivastava of the Uniformed Services University of Health Sciences, Bethesda, Maryland, and colleagues.

Srivastava et al. reported their findings in the journal Proceedings of the National Academy of Sciences ("HIV-1 Gag Shares A Signature Motif with Annexin (Anx7), Which Is Required for Virus Replication," Proc Natl Acad Sci U S A 1999 Mar 16;96(6):2704-9).

The human synexin molecule also contains a single copy of a modified PGQM motif. Synexin is a member of the annexin gene family and plays a role in the process of exocytosis. The PGQM motif may be important in this process as it cross-links with three distinct cellular proteins.

This work was supported by funds from the National Institutes of Health, a grant from the Commonwealth of Pennsylvania to the Biotechnology Foundation Inc., a grant from the Biomedical Research Support Committee, and institutional funds.

The corresponding author for this study is A. Srinivasan, Institute of Biotechnology and Advanced Molecular Medicine, Thomas Jefferson University, 1020 Locust St., Philadelphia, Pennsylvania 19107. Email: asrinivasan@redd1.uns.tju.edu.

990329
AW990315


Copyright © 1999 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990, 2000. AEGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ĘGIS, or the party credited as the provider of the content.